Our cluster of East-European countries is very attractive for clinical trials for a number of reasons:
■ ■ ■ Feasibility as a part of a study start-up determines the future course of the study. We identify the clinical sites that can provide intensive and high-quality recruitment. Finding appropriate sites is the challenge in the beginning and we simplify this task by exploring our network. Sometimes, the clinical site can be very successful in one indication but weaker in another. For new indications, we make a reassessment of the site potential that ensures quicker and higher enrollment. ■ ■ ■